IL6 and cancer: Upd3 is a homolog of human IL-6, which drives systemic inflammation and is often associated with cancer cachexia (Fearon et al., 2012; Jung and Choi, 2014; Petruzzelli and Wagner, 2016; Smitka and Marešová, 2015).